5-(5-bromo-1H-indol-3-ylmethylene)-thiazolidine-2,4-dione | 709621-60-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: 5-(5-bromo-1H-indol-3-ylmethylene)-thiazolidine-2,4-dione
• 英文别名: 5-[(5-bromo-1H-indol-3-yl)methylidene]-1,3-thiazolidine-2,4-dione
• CAS: 709621-60-3
• 化学式: C₁₂H₇BrN₂O₂S
• 分子量: 323.17
• InChiKey: ZJMRNKDBXYBSQT-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.25
• 重原子数：
  18.0
• 可旋转键数：
  1.0
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  61.96
• 氢给体数：
  2.0
• 氢受体数：
  3.0

反应信息

• 作为产物：
  描述：

  2,4-噻唑烷二酮 在 吗啉 、 5-溴吲哚-3-甲醛 作用下， 以 乙醇 为溶剂， 反应 1.17h， 以62.04%的产率得到5-(5-bromo-1H-indol-3-ylmethylene)-thiazolidine-2,4-dione
  参考文献：
  名称：

  新型吲哚衍生物作为有前途的DNA结合剂的合成以及抗肿瘤和抗拓扑异构酶I活性的评估

  摘要：

  带有吲哚核的分子具有多种生物学特性，例如抗肿瘤和抗炎活性，可以与DNA和蛋白质的相互作用相关。这项研究的重点是合成带有噻唑烷和咪唑烷环缩合成侧链的新吲哚衍生物，并评估它们与DNA相互作用的能力以及抗肿瘤和拓扑异构酶的抑制活性。已成功合成所有衍生物，并通过质谱（MS），红外（IR），光谱1 H NMR，13 C NMR，COZY 1 H- 1 H和HSQC 1 H- 13阐明了它们的结构C.使用抗增殖MTT测定法评估了针对不同癌细胞系的抗肿瘤活性。使用溴化乙锭（EB）作为荧光探针，通过吸收光谱法和荧光技术分析DNA结合能力。在与ctDNA（小牛胸腺DNA）相互作用后，除了光谱最大值的蓝移或红移以外，还观察到了化合物的光谱性质发生了变化，具有低变色和增色作用。吲哚衍生物5-（1 H-吲哚-3-基亚甲基）-噻唑烷-2,4-二酮（4c）在针对所测乳腺线（T47D）的抗肿瘤试验中表现出最佳结果，IC

  DOI：

  10.1016/j.ejmech.2017.05.012

文献信息

• Indole and 2,4-Thiazolidinedione conjugates as potential anticancer modulators
  作者：Domenica M. Corigliano、Riyaz Syed、Sebastiano Messineo、Antonio Lupia、Rahul Patel、Chittireddy Venkata Ramana Reddy、Pramod K. Dubey、Carmela Colica、Rosario Amato、Giovambattista De Sarro、Stefano Alcaro、Adisherla Indrasena、Antonio Brunetti

  DOI：10.7717/peerj.5386

  日期：——

  Thiazolidinediones (TZDs), also called glitazones, are five-membered carbon ring molecules commonly used for the management of insulin resistance and type 2 diabetes. Recently, many prospective studies have also documented the impact of these compounds as anti-proliferative agents, though several negative side effects such as hepatotoxicity, water retention and cardiac issues have been reported. In this work, we synthesized twenty-six new TZD analogues where the thiazolidinone moiety is directly connected to an N-heterocyclic ring in order to lower their toxic effects.

  By adopting a widely applicable synthetic method, twenty-six TZD derivatives were synthesized and tested for their antiproliferative activity in MTT and Wound healing assays with PC3 (prostate cancer) and MCF-7 (breast cancer) cells.

  Three compounds, out of twenty-six, significantly decreased cellular viability and migration, and these effects were even more pronounced when compared with rosiglitazone, a well-known member of the TZD class of antidiabetic agents. As revealed by Western blot analysis, part of this antiproliferative effect was supported by apoptosis studies evaluating BCL-xL and C-PARP protein expression.

  Our data highlight the promising potential of these TZD derivatives as anti-proliferative agents for the treatment of prostate and breast cancer.

  吡唑二酮类药物（TZDs），也称为格列酮，是常用于管理胰岛素抵抗和2型糖尿病的五元碳环分子。最近，许多前瞻性研究还记录了这些化合物作为抗增殖剂的影响，尽管已报告了一些负面副作用，如肝毒性、水潴留和心脏问题。在这项工作中，我们合成了二十六种新的TZD类似物，其中噻唑烷酮基团直接连接到N-杂环环，以降低其毒性作用。 通过采用一种广泛适用的合成方法，合成了二十六种TZD衍生物，并在MTT和伤口愈合实验中测试它们对PC3（前列腺癌）和MCF-7（乳腺癌）细胞的抗增殖活性。 在二十六种化合物中，有三种显著降低了细胞的存活率和迁移率，与罗格列酮（TZD类抗糖尿病药物的知名成员）相比，这些效应甚至更加显著。根据Western blot分析，部分这种抗增殖效应得到了通过评估BCL-xL和C-PARP蛋白表达的凋亡研究的支持。 我们的数据突显了这些TZD衍生物作为治疗前列腺癌和乳腺癌的抗增殖剂的潜在前景。
• Novel, Recyclable, and Thermally Stable Task-Specific Ionic Liquid (TBA Acetate) Medium/Catalyst for the Synthesis of Indolylidinecyclic-1,3- and -1,4-diketones
  作者：Sd. Riyaz、A. Indrasena、A. Naidu、P. Dubey

  DOI：10.1080/00397911.2013.806988

  日期：2014.2

  A simple and efficient synthesis of indolylidinethiazolidnediones (3) and indolylidinecyclic-1,3-diketones (5) has been developed by reaction of indole-3-aldehyde (1) with thiazolidinedione (2) or cyclic-1,3-diketones (4) using tetra butyl ammonium acetate (TBAA) melt as novel, cost-effective, and recyclable ionic liquid under solvent-free green conditions at 100 degrees C for 15-20min without additional use of catalyst. [Supplementary materials are available for this article. Go to the publisher's online edition of Synthetic Communications (R) for the following free supplemental resource(s): Full experimental and spectral details.]
• Designing of potential inhibitors against Staphylococcus aureus sortase A: Combined analogue and structure based approach with in vitro validation
  作者：K. Kranthi Raj、Veeramachaneni Ganesh Kumar、Chalasani Leela Madhuri、Pardhasaradhi Mathi、Ravulapati Durga Lakshmi、M. Ravi、B. Sri Ramudu、S.V. Venkata Rao、D. Ramachandran

  DOI：10.1016/j.jmgm.2015.05.009

  日期：2015.7

  Staphylococcus aureus sortase A is an attractive target of Gram-positive bacteria that plays a crucial role in anchoring of surface proteins to peptidoglycan present in bacterial cell wall. Inhibiting sortase A is an elementary and essential effort in preventing the pathogenesis. In this context, in silico virtual screening of in-house database was performed using ligand based pharmacophore model as a filter. The developed pharmacophore model AAHR 11 consists of two acceptors, one hydrophobic and one ring aromatic feature. Top ranked molecule KKR1 was docked into the active site of the target. After profound analysis, it was analyzed and optimized based on the observations from its binding pose orientation. Upgraded version of KKR1 was KKR2 and has improved docking score, binding interactions and best fit in the binding pocket. KKR1 along with KKR2 were further validated using 100 ns molecular dynamic studies. Both KKR1 and KKR2 contain Indole-thiazolidine moiety and were synthesized. The disk diffusion assay has good initial results (ZI of KKR1, KKR2 were 24, 38 mm at 10 mu g/mL and ZI of Ampicillin was 22 at 10 mu g/mL) and calculated MICs of the molecules (KKR1 5.56 +/- 0.28 mu g/mL, KKR2 1.32 +/- 0.12 mu g/mL, Ampicillin 8 +/- 1.1 mu g/mL) were in good agreement with standard drug Ampicillin. KKR1 has shown IC50 of 1.23 +/- 0.14 mu M whereas the optimized lead molecule KKR2 show IC50 of 0.008 +/- 0.07 mu M. Results from in silica were validated by in vitro studies and proved that indole-thiazolidine molecules would be useful for future development as lead molecules against S. aureus sortase A. (C) 2015 Elsevier Inc. All rights reserved.
• Synthesis of novel indole derivatives as promising DNA-binding agents and evaluation of antitumor and antitopoisomerase I activities
  作者：Elizabeth Almeida Lafayette、Sinara Mônica Vitalino de Almeida、Renata Virginia Cavalcanti Santos、Jamerson Ferreira de Oliveira、Cezar Augusto da Cruz Amorim、Rosali Maria Ferreira da Silva、Maira Galdino da Rocha Pitta、Ivan da Rocha Pitta、Ricardo Olimpio de Moura、Luiz Bezerra de Carvalho Júnior、Moacyr Jesus Barreto de Melo Rêgo、Maria do Carmo Alves de Lima

  DOI：10.1016/j.ejmech.2017.05.012

  日期：2017.8

  Molecules bearing indole nucleus present diverse biological properties such as antitumor and anti-inflammatory activities that can be associated both to DNA and protein interactions. This study focused on the synthesis of new indole derivatives with thiazolidines and imidazolidine rings condensed as side chains as well as the evaluation of their ability to interact with the DNA and antitumor and topoisomerase

  带有吲哚核的分子具有多种生物学特性，例如抗肿瘤和抗炎活性，可以与DNA和蛋白质的相互作用相关。这项研究的重点是合成带有噻唑烷和咪唑烷环缩合成侧链的新吲哚衍生物，并评估它们与DNA相互作用的能力以及抗肿瘤和拓扑异构酶的抑制活性。已成功合成所有衍生物，并通过质谱（MS），红外（IR），光谱1 H NMR，13 C NMR，COZY 1 H- 1 H和HSQC 1 H- 13阐明了它们的结构C.使用抗增殖MTT测定法评估了针对不同癌细胞系的抗肿瘤活性。使用溴化乙锭（EB）作为荧光探针，通过吸收光谱法和荧光技术分析DNA结合能力。在与ctDNA（小牛胸腺DNA）相互作用后，除了光谱最大值的蓝移或红移以外，还观察到了化合物的光谱性质发生了变化，具有低变色和增色作用。吲哚衍生物5-（1 H-吲哚-3-基亚甲基）-噻唑烷-2,4-二酮（4c）在针对所测乳腺线（T47D）的抗肿瘤试验中表现出最佳结果，IC